Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE Inhibitors vs ARBs in Hemodialysis Patients
NCT00878969Phase 3Terminated
- Sponsor
- Vanderbilt University
- Start
- Jan 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril, valsartan in chronic kidney disease (CKD), sponsored by Vanderbilt University. Started Jan 2010; status: terminated.
02
Drugs
ramiprilvalsartan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00878969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878969.